neostigmine has been researched along with Shingles in 2 studies
Neostigmine: A cholinesterase inhibitor used in the treatment of myasthenia gravis and to reverse the effects of muscle relaxants such as gallamine and tubocurarine. Neostigmine, unlike PHYSOSTIGMINE, does not cross the blood-brain barrier.
neostigmine : A quaternary ammonium ion comprising an anilinium ion core having three methyl substituents on the aniline nitrogen, and a 3-[(dimethylcarbamoyl)oxy] substituent at position 3. It is a parasympathomimetic which acts as a reversible acetylcholinesterase inhibitor.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
WALDMAN, S | 2 |
PELNER, L | 2 |
2 other studies available for neostigmine and Shingles
Article | Year |
---|---|
The treatment of essential (idiopathic) herpes zoster by thiamin potentiated with neostigmin.
Topics: Herpes Zoster; Herpesvirus 3, Human; Humans; Neostigmine; Thiamine | 1947 |
The treatment of herpes zoster, neuralgias, and neuritis with thiamine potentiated with neostigmine (thiastigmine).
Topics: Herpes Zoster; Humans; Neostigmine; Neuralgia; Neuritis; Thiamine | 1954 |